![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.460, 2004-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pneumococcal vaccination worth it for the elderly in Italy?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 522, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which vaccination strategy for Africa's meningitis belt?
Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which Strategy for Pertussis Vaccination Today?
By Girard D.Z.
Pediatric Drugs, Vol. 4, Iss. 5, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Universal hep A vaccination worth it in Canada?
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Measles vaccination campaigns worth the investment in S. Africa?
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :